The Sam Day Foundation reflects the spirit of Sam Day by choosing to Dream Big, Laugh Often, and Live Well.

  • Dream Big

Sam taught us to dream big and to be crazy enough to pursue our dreams.

  • We dream of raising the survival rates for rare pediatric cancers.
  • We dream of multiplying the treatment options for young people with cancer.
  • We dream of well funded research and attention for cancers that have previously been forgotten.
  • We dream of cancer treatments that don’t cause life-long impairments, infertility, and high risk for other cancers.
  • Laugh Often

Cancer is brutal. Life is hard. That is our reality. Laughter is essential for the human spirit to survive the brutality of pediatric cancer.

  • Our events will explode with fun and humor.
  • Our donors will surprise kids with adventures like summer camps, surf trips and vintage plane rides.
  • Our stories will remember the best of Sam and other young people who left us far too soon.
  • Our community will make some noise and demand change so kids with cancer can dream, laugh, and live.
  • Live Well

Above all, kids need to Live Well.

  • Kids with cancer will not just live, they will thrive.
  • Kids with cancer will be healthy and nourished.
  • Kids with cancer will be remembered and included.
  • Kids with cancer will know, we won’t give up on them.

Our 'Why'

Orphan Diseases

An orphan disease is a disease affecting less than 200,000 people in the US at any one time. Osteosarcoma is the most common type of sarcoma cancer, affecting 800 young people every year.

Years Of Limited Progress

Leukemia, the most common type of pediatric cancer, has a 90% cure rate. But orphan cancers like Ewing Sarcoma, have not seen changes in treatments in over 30 years.

People Die Each Day

Orphan cancers get very little funding from pharmaceutical companies to fund research for better treatments. Yet 276 young people die every day from cancer.

0 K
People Affected Each Year

Because orphan cancers affect less than 200,000 people per year, large drug companies don’t find financial incentive to invest in new drug exploration for pediatric cancers. Funding needs to come from private donations like ours.